Spots Global Cancer Trial Database for verteporfin
Every month we try and update this database with for verteporfin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00007969 | Melanoma (Skin) | Detox-B adjuvan... verteporfin | 18 Years - | National Cancer Institute (NCI) | |
| Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction | NCT06306638 | Malignant Solid... | Biospecimen Col... Computed Tomogr... Endobronchial U... Interstitial Ph... Palliative Radi... Physical Perfor... Questionnaire A... Verteporfin | 18 Years - | Roswell Park Cancer Institute | |
| Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors | NCT00002647 | Brain and Centr... Metastatic Canc... | verteporfin conventional su... | 3 Years - 70 Years | National Cancer Institute (NCI) | |
| An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer | NCT02939274 | Metastatic Brea... | Verteporfin Continuous Low-... | 18 Years - | Rogers Sciences Inc. | |
| Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer | NCT06381154 | Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Biopsy Biospecimen Col... Computed Tomogr... Endoscopic Ultr... Fluorouracil Irinotecan Leucovorin Lymph Node Biop... Magnetic Resona... Oxaliplatin Pembrolizumab Photodynamic Th... Positron Emissi... Questionnaire A... Verteporfin | 18 Years - | Mayo Clinic | |
| Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction | NCT06306638 | Malignant Solid... | Biospecimen Col... Computed Tomogr... Endobronchial U... Interstitial Ph... Palliative Radi... Physical Perfor... Questionnaire A... Verteporfin | 18 Years - | Roswell Park Cancer Institute | |
| Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study | NCT04429139 | Retinoblastoma | photodynamic th... | 1 Year - 20 Years | Sun Yat-sen University | |
| HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies | NCT03906643 | Solid Tumor | HS-201 | 18 Years - 99 Years | Duke University | |
| Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies | NCT02702700 | Pleural Effusio... | Cisplatin, lipo... Verteporfin Device for Intr... | 18 Years - 80 Years | Centre Hospitalier Universitaire Vaudois | |
| HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies | NCT03906643 | Solid Tumor | HS-201 | 18 Years - 99 Years | Duke University | |
| Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma | NCT04590664 | Glioblastoma Recurrent Gliob... | Verteporfin | 18 Years - | Emory University | |
| Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00007969 | Melanoma (Skin) | Detox-B adjuvan... verteporfin | 18 Years - | National Cancer Institute (NCI) | |
| Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study | NCT04429139 | Retinoblastoma | photodynamic th... | 1 Year - 20 Years | Sun Yat-sen University | |
| Treatment of Primary Breast Cancer Using PDT | NCT02872064 | Breast Neoplasm... | Verteporfin | 30 Years - | University College, London | |
| Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer | NCT06381154 | Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Biopsy Biospecimen Col... Computed Tomogr... Endoscopic Ultr... Fluorouracil Irinotecan Leucovorin Lymph Node Biop... Magnetic Resona... Oxaliplatin Pembrolizumab Photodynamic Th... Positron Emissi... Questionnaire A... Verteporfin | 18 Years - | Mayo Clinic | |
| Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study | NCT03033225 | Advanced Pancre... Locally Advance... Metastatic Panc... Pancreatic Neop... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Endoscopic Ultr... Fluorescence Im... Photodynamic Th... Quality-of-Life... Questionnaire A... Verteporfin | 18 Years - | Mayo Clinic | |
| Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma | NCT00007969 | Melanoma (Skin) | Detox-B adjuvan... verteporfin | 18 Years - | National Cancer Institute (NCI) | |
| Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study | NCT04429139 | Retinoblastoma | photodynamic th... | 1 Year - 20 Years | Sun Yat-sen University | |
| Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System | NCT03067051 | Recurrent Prost... | Verteporfin SpectraCure P18... | 18 Years - | SpectraCure AB |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
